KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors
Jazyk angličtina Země Irsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28624668
DOI
10.1016/j.diabres.2017.05.018
PII: S0168-8227(17)30329-7
Knihovny.cz E-zdroje
- Klíčová slova
- DPP-4 inhibitors, KCNQ1, Pharmacogenetics, Type 2 diabetes,
- MeSH
- alely MeSH
- diabetes mellitus 2. typu farmakoterapie genetika MeSH
- draslíkový kanál KCNQ1 genetika MeSH
- genotyp MeSH
- glykovaný hemoglobin analýza MeSH
- inhibitory dipeptidylpeptidasy 4 terapeutické užití MeSH
- krevní glukóza analýza MeSH
- lidé středního věku MeSH
- lidé MeSH
- polymorfismus genetický genetika MeSH
- retrospektivní studie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- draslíkový kanál KCNQ1 MeSH
- glykovaný hemoglobin MeSH
- inhibitory dipeptidylpeptidasy 4 MeSH
- krevní glukóza MeSH
AIMS: Only afew gene variants were associated with the response to dipeptidylpeptidase-4 inhibitors (DPP4I). KCNQ1 gene variants were previously related both to type 2 diabetes (T2D) and incretin effect. We hypothesized that T2D related KCNQ1 variants would be associated with smaller glucose-lowering effect of DDP4I. METHODS: We performed a retrospective study in 137 Caucasian subjects with T2D who were followed for 6months after initiation of DPP4I treatment. Genotyping for KCNQ1 rs163184 and rs151290 was performed using PCR-HRMA and PCR-RFLP methods, respectively. The main clinical outcome was reduction in HbA1c (ΔHbA1c) after 6-month DPP4I treatment. RESULTS: KCNQ1 rs163184 T>G variant was associated with the response to DPP4I treatment in genetic additive model (β=-0.30, p=0.022). For each G allele in the rs163184 genotype, we observed a 0.3% (3.3mmol/mol) less reduction in HbA1c during treatment with a DPP4I. Both the GG homozygotes and G-allele carriers had significantly smaller HbA1c reduction in comparison with the TT homozygotes. CONCLUSIONS: KCNQ1 rs163184 T>G variant was associated with a reduced glycaemic response to DPP4I. The difference of 0.6% (6.5mmol/mol) in HbA1c reduction between the TT and GG homozygotes might be of clinical significance if replicated in further studies.
L Pasteur University Hospital Košice Slovakia
Citace poskytuje Crossref.org